Literature DB >> 2500265

Zinc acetate pretreatment ameliorates cisplatin-induced Sertoli cell dysfunction in Sprague-Dawley rats.

L M Pogach1, Y Lee, W Giglio, M Naumoff, H F Huang.   

Abstract

The present study was undertaken to determine if prior administration of zinc acetate (ZnAc) or copper sulfate (CuSO4) could prevent pituitary, Leydig, or Sertoli cell dysfunction subsequent to cisplatin administration in adult Sprague-Dawley rats. Animals were given cisplatin at a dose of 2 mg/kg daily for 5 days, with or without the i.p. administration of ZnAc (6 mg/kg per day) or CuSO4 (5 mg/kg per day), beginning 5 days prior to and continuing through the administration of cisplatin. Control animals were given vehicle, ZnAc1, or CuSO4. Animals were sacrificed 1 week after the initial cisplatin injection. Cisplatin administration resulted in suppressed serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels as well as a 77% reduction in serum testosterone and an 82% reduction in testicular testosterone. The concomitant administration of either ZnAc or CuSO4 did not result in a significant difference relative to animals receiving cisplatin alone, although administration of both cations alone significantly reduced testicular testosterone content. Serum androgen-binding protein (ABP) was not significantly lowered in any treatment group. There was a marked reduction of 57% in testicular ABP content relative to control values subsequent to cisplatin administration. This reduction was partially prevented by ZnAc treatment: the testicular ABP concentration was only 15% lower than that in controls (not significant). Since the cisplatin-induced reduction in serum FSH was not altered by ZnAc pretreatment, we conclude that the near normalization of testicular ABP content may be evidence of improved Sertoli cell function. In contrast, cisplatin-induced decreases in the serum gonadotropins and testicular androgens were not lessened by pretreatment with either cation. Further studies may be warranted to determine whether ZnAc pretreatment has a beneficial effect on spermatogenesis during cisplatin treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500265     DOI: 10.1007/bf00300239

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  20 in total

1.  Characterization of cis-platinum-induced Sertoli cell dysfunction in rodents.

Authors:  L M Pogach; Y Lee; S Gould; W Giglio; M Meyenhofer; H F Huang
Journal:  Toxicol Appl Pharmacol       Date:  1989-04       Impact factor: 4.219

2.  Metabolism of platinum ( 14 C)ethylenediamine dichloride in the rat.

Authors:  D M Taylor; J D Jones; A B Robins
Journal:  Biochem Pharmacol       Date:  1973-04-01       Impact factor: 5.858

3.  Inhibition of testicular cytochrome P-450-dependent steroid biosynthesis by cis-platinum. Reversal by human chorionic gonadotropin.

Authors:  M D Maines; R D Mayer
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

4.  [Testis and heavy metals].

Authors:  F Timm; G Schulz
Journal:  Histochemie       Date:  1966

Review 5.  Drugs five years later. Cisplatin.

Authors:  P J Loehrer; L H Einhorn
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

6.  Cisplatinum: effect of zinc acetate pretreatment on cellular uptake and interactions with cytosolic ligands.

Authors:  R P Sharma
Journal:  Toxicology       Date:  1984-07       Impact factor: 4.221

7.  Effect of copper pretreatment on toxicity and antitumor activity of cis-diamminedichloroplatinum in mice.

Authors:  A Naganuma; M Satoh; N Imura
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-11

8.  Effect of a chelating drug on balance and tissue distribution of four essential metals.

Authors:  T J Solecki; A Aviv; J D Bogden
Journal:  Toxicology       Date:  1984-06       Impact factor: 4.221

9.  Protective effect of metallothionein inducing metals on lethal toxicity of cis-diamminedichloroplatinum in mice.

Authors:  A Naganuma; M Satoh; Y Koyama; N Imura
Journal:  Toxicol Lett       Date:  1985 Feb-Mar       Impact factor: 4.372

10.  Resistance to cadmium-induced necrosis in testes of inbred mice: possible role of a metallothionein-like cadmium-binding protein.

Authors:  G J Chellman; Z A Shaikh; R B Baggs; G L Diamond
Journal:  Toxicol Appl Pharmacol       Date:  1985-07       Impact factor: 4.219

View more
  2 in total

1.  Effects of carboplatin on the testis. A histological study.

Authors:  P Köpf-Maier
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Metallothionein and anticancer agents: the role of metallothionein in cancer chemotherapy.

Authors:  F Doz; N Roosen; M L Rosenblum
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.